ALAR , Light up Your Life
Recent Alar News
13 January, 2022
Alar Announces Significant Progress on Developing long-acting Buprenorphine
Injectable ALA-1000.
09 November, 2021
Alar Announce Results from ALA-1000 Single Ascending Dose Study in Opioid Dependent Patients.
28 October, 2021
Alar Pharmaceuticals Inc. Completes Successful End-of-Phase 2 Meeting with US FDA for ALA-1000 for the Treatment of Opioid Use Disorder
16 August, 2021
Alar Pharmaceuticals Announces H1 Financial Results